White label – Pompe disease - ClinicalTrials.eu

Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

Recruiting

2 1 1
Investigated Diseases:
- Cholangitis sclerosing
Investigated Drugs:
- Simvastatin
Study on the Effectiveness and Safety of Tinengotinib for Patients with Cholangiocarcinoma Resistant to Chemotherapy and FGFR Inhibitors

Recruiting

3 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
+2
Study on the Effectiveness and Safety of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Recruiting

3 1 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Risdiplam
Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Temsirolimus
- Crizotinib
+3
Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments

Recruiting

3 1
Investigated Diseases:
- Psoriatic arthropathy
Investigated Drugs:
- Risankizumab
+4
Study of BGB-11417 and Azacitidine for Patients with Myeloid Malignancies (AML, MDS, MDS/MPN)

Recruiting

1 1 1 1
Investigated Drugs:
Study of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy

Recruiting

1 1 1 1
Investigated Drugs:
- Anti-(Fc Fragment Of Igg Receptor Iib) Monoclonal Antibody Bi-1206
- Pembrolizumab
Study on the Safety of AZD8421 Alone or with Drug Combination for Patients with Advanced Breast Cancer and High-Grade Ovarian Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

Recruiting

4 1 1
Investigated Diseases:
- Systemic scleroderma
- Interstitial lung disease
Investigated Drugs:
- Belimumab
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies